CVS/Caremark Merger Expected To Close Promptly Following Shareholder Approval
This article was originally published in The Pink Sheet Daily
Executive Summary
Caremark shareholders vote in favor of CVS’ roughly $27 billion acquisition, ending Express Scripts’ hostile bid for the pharmacy benefit manager.